Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–3 of 3 results
Advanced filters: Author: Sarah C. Erlandson Clear advanced filters
  • The RXFP1 relaxin receptor is a critical mediator of physiological adaptation to pregnancy and an emerging drug target. RXFP1 activation was found to entail an unexpected mechanism of ectodomain disinhibition resulting in downstream signaling.

    • Sarah C. Erlandson
    • Shaun Rawson
    • Andrew C. Kruse
    Research
    Nature Chemical Biology
    Volume: 19, P: 1013-1021
  • Yeast surface display platform allows nanobody discovery within two to three weeks. Examples include nanobodies for crystallographic applications, targeting nonpurified antigen or conformationally selective nanobodies to two distinct human GPCRs.

    • Conor McMahon
    • Alexander S. Baier
    • Andrew C. Kruse
    Research
    Nature Structural & Molecular Biology
    Volume: 25, P: 289-296